INVENTISBIO
InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company is co-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
INVENTISBIO
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2013-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.inventisbio.com
Total Employee:
1+
Status:
Active
Total Funding:
247 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Wordpress Plugins Nginx Euro Microsoft Exchange Online
Similar Organizations
Genevide
Genevide is a biotech company that specializes in gene research and development.
New Amsterdam Pharma
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Teligene
Teligene is a drug discovery company edicating to developing innovative small-molecule drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Dyee Capital
Dyee Capital investment in Series D - InventisBio
Janchor Partners
Janchor Partners investment in Series D - InventisBio
Qiming Venture Partners
Qiming Venture Partners investment in Series D - InventisBio
E Fund Management Co.,LTD.
E Fund Management Co.,LTD. investment in Series D - InventisBio
Pudong Innotek
Pudong Innotek investment in Series D - InventisBio
Matrix Partners China
Matrix Partners China investment in Series D - InventisBio
Lilly Asia Ventures
Lilly Asia Ventures investment in Series D - InventisBio
GL Ventures
GL Ventures investment in Series D - InventisBio
CMB International Capital Corporation
CMB International Capital Corporation investment in Series D - InventisBio
Advantech Capital
Advantech Capital investment in Series D - InventisBio
Official Site Inspections
http://www.inventisbio.com
- Host name: 139.224.229.15
- IP address: 139.224.229.15
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "InventisBio"
็ๆน็็ฉ็งๆ๏ผไธๆตท๏ผ่กไปฝๆ้ๅ ฌๅธ - inventisbio.com
InventisBio is a clinical stage biotech company with two drugs approved and three candidates in clinical trials with the most advanced one in a phase 3 registration trials in China. We are โฆSee details»
inventisbio.com - ็ๆน็็ฉ็งๆ๏ผไธๆตท๏ผ่กไปฝๆ้ๅ ฌๅธ
็ๆน็็ฉๆฏไธๅฎถ็ซ่ถณไธญๅฝๅ ทๆๅ จ็่ง้็ๅๆฐๅ่ฏ็ฉ็ ๅไผไธใๅ ฌๅธ็ไบงๅไธป่ฆ่็ฆไบ่ฟ็คใไปฃ่ฐขๅ่ช่บซๅ ็ซๆง็พ็ ็ญ้ๅคง็พ็ ้ขๅ๏ผๅไธบ่ชไธป็ ๅใๆช่ณ็ฎๅ๏ผ็ๆน็็ฉ็ไบงๅ็ฎก็บฟๆ2ไธช่ท โฆSee details»
Company Introduction โ ็ๆน็็ฉ็งๆ๏ผไธๆตท๏ผ่กไปฝๆ้ๅ ฌๅธ
Company Introduction InventisBio is a clinical stage biotech company with two drugs approved and three candidates in clinical trials with the most advanced one in a phase 3 registration โฆSee details»
InventisBio - Crunchbase Company Profile & Funding
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.See details»
InventisBio Co., Limited (688382.SS) - Yahoo Finance
Find the latest InventisBio Co., Limited (688382.SS) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
InventisBio Announces Positive Phase 2 Study Results for D-2570 โฆ
Dec 3, 2024 InventisBio Co., Ltd. today announced promising results from a Phase 2 clinical trial of D-2570, an oral selective inhibitor of the TYK2 kinase, in patients with moderate to severe โฆSee details»
InventisBio - Financial Details - Crunchbase
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.See details»
InventisBio (SHA:688382) Company Profile & Description
Aug 7, 2025 Company profile for InventisBio Co., Limited (SHA:688382) with a description, list of executives, contact details and other key facts.See details»
InventisBio Inc. (CN) - [LSUS] Life-Sciences-USA.com - The ...
Jan 1, 2016 InventisBio is a clinical stage biotech company dedicated to the discovery and development of novel therapeutics against cancer and metabolic diseases. The company has โฆSee details»
InventisBio, Co., Ltd. - Drug pipelines, Patents, Clinical trials
Jun 1, 2023 Explore InventisBio, Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 34 clinical trials, 19 news, and 2 literature, Disease Domain:Neoplasms ...See details»
InventisBio Co., Limited: Governance, Directors and Executives ...
Mar 31, 2025 InventisBio Co Ltd is a China-based company mainly engaged in the research and development of innovative drugs. The Company's main product is still in clinical development.See details»
InventisBio - 2025 Company Profile & Team - Tracxn
Jun 25, 2025 Explore InventisBio's in-depth company profile, including funding details, key investors, leadership, and competitors.See details»
InventisBio Company Profile - Office Locations, Competitors ... - Craft
InventisBio has 5 employees across 2 locations and $236 m in total funding,. See insights on InventisBio including office locations, competitors, revenue, financials, executives, subsidiaries โฆSee details»
About InventisBio Co Ltd (688382) - Investing.com Canada
This page offers an in-depth profile of InventisBio Co Ltd, including a general overview of the company's business and key management.See details»
Organization: InventisBio
Profile InventisBio Co., Ltd. develops biotechnology products. The Company produces tumor drugs, metabolic drugs, lung cancer drugs, breast cancer drugs, gout drugs, and other related โฆSee details»
InventisBio - Org Chart, Teams, Culture & Jobs | The Org
View InventisBio's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Organization | InventisBio Inc.
InventisBio Inc. Report issue For profit Phase 1 Phase 2 Founded: Shanghai China (2013) Organization Overview First Clinical Trial 2017 NCT03291782 First Marketed Drug None First โฆSee details»
Inventisbio: Employee Directory | ZoomInfo.com
Inventisbio Employee Directory Inventisbio corporate office is located in 25a Hanover Rd Ste 340, Florham Park, New Jersey, 07932, United States and has 42 employees.See details»
InventisBio Co Ltd, 688382:SHH profile - FT.com
Jul 23, 2025 InventisBio Co Ltd (688382:SHH) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Company InventisBio Co., Ltd. - ca.marketscreener.com
Business Summary InventisBio Co Ltd is a China-based company mainly engaged in the research and development of innovative drugs. The Company's main product is still in clinical โฆSee details»